Tower Research Capital (TRC)’s Hepion Pharmaceuticals HEPA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-110
| Closed | -$47 | – | 5384 |
|
|
2025
Q1 | $47 | Sell |
110
-6
| -5% | -$3 | ﹤0.01% | 5078 |
|
|
2024
Q4 | $2.74K | Sell |
116
-21
| -15% | -$495 | ﹤0.01% | 4783 |
|
|
2024
Q3 | $4.59K | Buy |
137
+21
| +18% | +$703 | ﹤0.01% | 4488 |
|
|
2024
Q2 | $5.92K | Buy |
116
+78
| +205% | +$3.98K | ﹤0.01% | 4640 |
|
|
2024
Q1 | $4.73K | Buy |
38
+6
| +19% | +$747 | ﹤0.01% | 4640 |
|
|
2023
Q4 | $5.24K | Sell |
32
-12
| -27% | -$1.97K | ﹤0.01% | 4863 |
|
|
2023
Q3 | $11.1K | Buy |
44
+39
| +780% | +$9.8K | ﹤0.01% | 4041 |
|
|
2023
Q2 | $2.79K | Sell |
5
-6
| -55% | -$3.35K | ﹤0.01% | 5127 |
|
|
2023
Q1 | $8K | Sell |
11
-21
| -66% | -$15.3K | ﹤0.01% | 4633 |
|
|
2022
Q4 | $10K | Buy |
32
+12
| +60% | +$3.75K | ﹤0.01% | 4006 |
|
|
2022
Q3 | $10K | Buy |
20
+8
| +67% | +$4K | ﹤0.01% | 4535 |
|
|
2022
Q2 | $7K | Buy |
12
+10
| +500% | +$5.83K | ﹤0.01% | 4792 |
|
|
2022
Q1 | $2K | Buy |
+2
| New | +$2K | ﹤0.01% | 5556 |
|
|
2021
Q3 | – | Sell |
-3
| Closed | -$7K | – | 5921 |
|
|
2021
Q2 | $7K | Sell |
3
-22
| -88% | -$51.3K | ﹤0.01% | 4556 |
|
|
2021
Q1 | $46K | Buy |
+25
| New | +$46K | ﹤0.01% | 3194 |
|
|
2020
Q4 | – | Sell |
-5
| Closed | -$14K | – | 5245 |
|
|
2020
Q3 | $14K | Buy |
+5
| New | +$14K | ﹤0.01% | 3963 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4646 |
|
|
2016
Q1 | – | Hold |
0
| – | -$3K | – | 4460 |
|
|
2015
Q4 | – | Hold |
0
| – | -$7K | – | 3446 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 2556 |
|
|
2015
Q2 | – | Hold |
0
| – | -$3K | – | 4647 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 3564 |
|